| Literature DB >> 25401785 |
Tim Lane1, Thomas Osmand1, Alexander Marr1, Starley B Shade1, Kristin Dunkle2, Theodorus Sandfort3, Helen Struthers4, Susan Kegeles1, James A McIntyre5.
Abstract
The Mpumalanga Men's Study (MPMS) is the assessment of the Project Boithato HIV prevention intervention for South African MSM. Boithato aims to increase consistent condom use, regular testing for HIV-negative MSM, and linkage to care for HIV-positive MSM. The MPMS baseline examined HIV prevalence and associated risk behaviors, and testing, care, and treatment behaviors among MSM in Gert Sibande and Ehlanzeni districts in Mpumalanga province, South Africa in order to effectively target intervention activities. We recruited 307 MSM in Gert Sibande and 298 in Ehlanzeni through respondent-driven sampling (RDS) between September 2012-March 2013. RDS-adjusted HIV prevalence estimates are 28.3% (95% CI 21.1%-35.3%) in Gert Sibande, and 13.7% (95% CI 9.1%-19.6%) in Ehlanzeni. Prevalence is significantly higher among MSM over age 25 [57.8% (95% CI 43.1%-72.9%) vs. 17.9% (95% CI 10.6%-23.9%), P<0.001 in Gert Sibande; 34.5% (95%CI 20.5%-56.0%) vs. 9.1% (95% CI 4.6%-13.9%), P<0.001 in Ehlanzeni]. In Gert Sibande, prevalence is higher among self-identified gay and transgender MSM vs. other MSM [39.3% (95%CI, 28.3%-47.9%), P<0.01], inconsistent condom users [38.1% (18.1%-64.2%), P<0.05], those with a current regular male partner [35.0% (27.1%-46.4%), P<0.05], and those with lifetime experience of intimate partner violence with men [40.4%, (95%CI 28.9%-50.9%), P<0.05]. Prevalence of previous HIV testing was 65.8% (95%CI 58.8%-74.0%) in Gert Sibande, and 69.3% (95%CI 61.9%-76.8%) in Ehlanzeni. Regular HIV testing was uncommon [(34.6%, (95%CI 27.9%-41.4%) in Gert Sibande; 31.0% (95%CI 24.9%-37.8%) in Ehlanzeni]. Among HIV-positive participants, few knew their status (28.1% in Gert Sibande and 14.5% in Ehlanzeni), or were appropriately linked to care (18.2% and 11.3%, respectively), or taking antiretroviral therapy (13.6% and 9.6% respectively). MPMS results demonstrate the importance of implementing interventions for MSM to increase consistent condom use, regular HIV testing, and linkage and engagement in care for HIV-infected MSM.Entities:
Mesh:
Year: 2014 PMID: 25401785 PMCID: PMC4234301 DOI: 10.1371/journal.pone.0111063
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Location of Gert Sibande and Ehlanzeni District Municipalities, Mpumalanga Province, South Africa.
Figure 2Plausibility Bounds of Undiagnosed HIV Infection.
The graph indicates the upper and lower plausibility bounds of undiagnosed infection in Mpumalanga MSM. We estimate that between 16.3% and 20.6% of MSM in Gert Sibande, and 12.5% and 25.2% in Ehlanzeni, currently have an undiagnosed HIV infection. This range between lower and upper plausibility boundaries accounts for the small number of participants at each site who declined testing. The upper plausibility bound assumes all untested participants are HIV-positive, and the lower assumes all untested participants are HIV-negative.
Demographic Indicators for Mpumalanga Men's Study.
| Measure | Gert Sibande (N = 307) | Ehlanzeni (N = 298) | |||||||
| Crude | Adjusted | Crude | Adjusted | ||||||
| N | % | % | 95% CI | N | % | % | 95% CI | ||
| Age | |||||||||
| 18–24 | 199 | 64.8 | 70.4 | 62.8–77.5 | 206 | 69.6 | 72 | 63.1–77.4 | |
| 25+ | 108 | 35.2 | 29.6 | 22.5–37.2 | 90 | 30.4 | 28 | 22.6–36.9 | |
| Highest Education Attained | |||||||||
| Secondary or less | 199 | 65.5 | 64.2 | 55.1–71.4 | 121 | 41.2 | 47.3 | 38.2–54.3 | |
| Tertiary | 105 | 34.5 | 35.8 | 28.6–45.0 | 173 | 58.8 | 52.7 | 45.7–61.8 | |
| Employment in Last 6 Months | |||||||||
| Had paid work | 122 | 39.7 | 35.7 | 28.9–44.1 | 129 | 43.3 | 40.7 | 34.4–49.7 | |
| No paid work | 185 | 60.3 | 64.3 | 55.9–71.1 | 169 | 56.7 | 59.3 | 50.3–65.6 | |
| Ran out of Money for Basic Needs in Last 6 Months | |||||||||
| Never/Rarely | 148 | 48.2 | 45 | 37.6–53.1 | 169 | 56.7 | 45.6 | 38.7–54.0 | |
| Sometimes/Often/Always | 159 | 51.8 | 55 | 46.9–62.4 | 129 | 43.3 | 54.4 | 46.0–61.3 | |
| Sexual Orientation | |||||||||
| Gay/Homosexual | 163 | 53.1 | 46.6 | 38.3–55.5 | 151 | 50.7 | 44.5 | 26.6–44.1 | |
| Bisexual | 128 | 41.7 | 45.4 | 37.3–53.7 | 92 | 30.9 | 35.3 | 36.0–51.7 | |
| Heterosexual | 13 | 4.2 | 7.3 | NC | 7 | 2.4 | 4.5 | NC | |
| Trans/Woman | 1 | 0.3 | 0.1 | NC | 5 | 1.7 | 0.6 | NC | |
| Other | 0 | 0 | 0 | NC | 4 | 1.3 | 2 | NC | |
| None Reported | 2 | 0.7 | 0.6 | NC | 39 | 13.1 | 13.1 | 7.7–20.3 | |
NC = Not calculated due to small cell size.
Associations between HIV infection and demographic and behavioural indicators in Mpumalanga Men's Study.
| Measure | Gert Sibande (N = 307) | Ehlanzeni (N = 298) | ||
| Adj % (95% CI) | Adj % (95% CI) | |||
| Age | ||||
| 18–24 | 17.9 (10.6–23.9) | 9.1 (4.6–13.9) | ||
| 25+ | 57.8 (43.1–72.9)*** | 34.5 (20.5–56.0)*** | ||
| Sexual Identity | ||||
| Gay/Trans/Woman | 39.3 (26.1–48.2) | 13.8 (8.3–21.7) | ||
| Bisexual | 20.2 (11.4–28.8) | 21.3 (10.5–31.2) | ||
| None Reported | NC | 14.4 (0.0–34.9) | ||
| Current Regular Female Partner | 20.7 (8.3–28.1) | 13.4 (1.0–14.6) | ||
| Male Partners | ||||
| Current regular male partner | 35.0 (27.1–46.4)** | 15.0 (8.8–23.3) | ||
| Past regular male partners | 16.1 (7.2–30.5) | 6.8 (0.0–21.1) | ||
| Never had a regular male partner | 7.6 (0.5–20.2) | 24.5 (8.6–40.2) | ||
| Transactional Sex | ||||
| Received money, goods, services | 29.50 (15.2–49.5) | 13.5 (2.9–39.6) | ||
| Provided money, goods, services | 42.70 (16.8–70.4) | NC | ||
| Condom Use with Male Partner (6 months) | ||||
| Consistent | 26.6 (19.2–35.3) | 26.7 (17.2–34.3) | ||
| Inconsistent | 38.1 (18.1–64.2) | 11.6 (6.0–19.9) | ||
| Alcohol Consumption | ||||
| "Heavy drinkers" | 30.8 (18.2–39.7) | 18.2 (8.–27.5) | ||
| Never drank heavily | 22.4 (9.8–35.4) | 18.7 (10.2–31.3) | ||
| Marijuana Use (6 Months) | 14.4 (2.7–30.3) | NC | ||
| IPV with Male Partners | 40.4 (28.9–50.9) | NC | ||
| Negative Result on Last HIV Test | 16.2 (8.8–22.9) | 14.3 (3.5–17.0) | ||
*p<0.05, **p<0.01, ***p<0.001 NC = Not calculated due to small cell size.
Utilization of Testing and Care Among HIV+ MSM in Mpumalanga Men's Study.
| Measure | Gert Sibande (N = 307) | Ehlanzeni (N = 298) | ||
| % (n) | % (n) | |||
| HIV Rapid Test Result Positive | 35.8 (110) | 20.8 (62) | ||
| Previously aware of HIV positive status | 28.1 (31) | 14.5 (9) | ||
| Linked to care | 18.2 (20) | 11.3 (7) | ||
| Currently taking ART | 13.6 (15) | 9.6 (6) | ||
| Newly diagnosed HIV+ | 71.8 (79) | 85.4 (53) | ||
| Never tested for HIV | 31.6 (25) | 37.7 (20) | ||
| Recent HIV infection (12 months) | 22.1 (30) | 39.6 (21) | ||
NB: Figures are not RDS-adjusted estimates; all variables other than rapid results are self-reported.
Behavioural and HIV Indicators in Mpumalanga Men's Study.
| Measure | Gert Sibande (N = 307) | Ehlanzeni (N = 298) | ||||||||
| Crude | Adjusted | Crude | Adjusted | |||||||
| N | % | % | 95% CI | N | % | % | 95% CI | |||
| Female Partners | ||||||||||
| Current regular female partner | 113 | 38.6 | 40.6 | 32.2–48.9 | 67 | 22.7 | 25.7 | 18.05–33.2 | ||
| Past female partners | 85 | 27.7 | 32.3 | 24.9–40.2 | 67 | 22.7 | 23.2 | 17.5–29.9 | ||
| Never had a female partner | 109 | 35.5 | 27.1 | 19.4–35.7 | 161 | 54.6 | 51.1 | 43.4–58.2 | ||
| Male Partners | ||||||||||
| Current regular male partner | 215 | 70.5 | 66.0 | 58.2–73.7 | 224 | 75.7 | 74.2 | 65.9–79.9 | ||
| Past regular male partner | 63 | 20.7 | 21.7 | 7.3–18.5 | 21 | 7.1 | 5.7 | 2.4–11.5 | ||
| Never had a male partner | 27 | 8.9 | 12.2 | 7.3–18.5 | 51 | 17.2 | 20.1 | 14.2–27.5 | ||
| Number of Female Partners in Last 6 Months | ||||||||||
| None | 286 | 93.2 | 91.9 | 88.5–95.3 | 292 | 98.0 | 97.7 | 95.7–99.3 | ||
| > = 1 Partner | 21 | 6.8 | 8.1 | 4.7–11.5 | 6 | 2.0 | 2.3 | NC | ||
| Number of Male Partners in Last 6 Months | ||||||||||
| = 1 Partner | 188 | 61.2 | 70.3 | 62.8–76.4 | 172 | 57.7 | 62.2 | 53.5–69.0 | ||
| > = 2 Partners | 119 | 38.8 | 29.7 | 23.6–37.2 | 126 | 42.3 | 37.8 | 31.0–46.5 | ||
| Transactional Sex | ||||||||||
| Received money, other goods | 57 | 18.6 | 21.1 | 14.8–28.5 | 34 | 11.4 | 13.2 | 81.9–92.0 | ||
| Gave money, other goods | 35 | 11.4 | 12.7 | 8.0–19.0 | 22 | 7.4 | 9.0 | 4.2–14.0 | ||
| Condom Use with Last 5 Male Partners | ||||||||||
| Consistent | 244 | 83.3 | 85.1 | 78.2–90.7 | 169 | 58.9 | 63.7 | 55.9–70.1 | ||
| Inconsistent | 49 | 16.7 | 14.9 | 9.3–21.8 | 118 | 41.1 | 36.3 | 29.9–44.1 | ||
| Drink> = 6 Drinks in One Sitting | ||||||||||
| Never | 49 | 16 | 17.4 | 11.4–23.4 | 127 | 42.6 | 41.3 | 34.9–49.3 | ||
| <1/month | 114 | 37.1 | 42.7 | 34.2–50.9 | 68 | 22.8 | 23.9 | 16.3–28.8 | ||
| 2–4 times/month | 141 | 45.9 | 39.9 | 32.5–48.5 | 79 | 26.5 | 26.5 | 20.8–33.8 | ||
| 2–3 times/week | 0 | 0 | 0 | NC | 17 | 5.7 | 6.6 | 3.4–10.8 | ||
| More than 4 times/week | 3 | 1 | 0 | NC | 7 | 2.3 | 1.6 | NC | ||
| Marijuana | ||||||||||
| Used in past 6 months | 35 | 11.4 | 8.2 | 4.6–11.6 | 7 | 2.3 | 0.4 | NC | ||
| Partner Violence | ||||||||||
| Any victimization in past 6 months | 142 | 46.3 | 38.4 | 29.8–46.1 | 37 | 12.4 | 12.8 | 7.8–19.1 | ||
| HIV Testing Behavior | ||||||||||
| Ever Tested in Lifetime | ||||||||||
| Yes | 223 | 72.6 | 65.8 | 58.8–74.0 | 213 | 71.5 | 69.3 | 61.9–76.8 | ||
| No | 84 | 27.4 | 34.2 | 26.0–41.2 | 85 | 28.5 | 30.7 | 23.2–38.1 | ||
| Regular Tester | 115 | 37.5 | 34.6 | 27.9–41.4 | 97 | 32.6 | 31.0 | 24.9–37.8 | ||
| HIV Rapid Test Result | ||||||||||
| Positive | 110 | 35.8 | 28.3 | 21.1–35.3 | 62 | 20.8 | 13.7 | 9.1–19.6 | ||
| Negative | 185 | 60.3 | 67.8 | 61.0–75.4 | 197 | 66.1 | 72.4 | 65.2–78.5 | ||
| Not Tested | 12 | 3.9 | 3.9 | 1.4–6.5 | 39 | 13.1 | 13.9 | 8.8–19.8 | ||
NC = Not calculated due to small cell size.
“Regular tester”:>1 lifetime HIV test & tests every 6 months.